Erythropoietin Drugs Market Size, Share, Trends, Industry Analysis Report: By Type (Biologics and Biosimilars), Product, Application, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa)

Description

List of Tables

The global erythropoietin drugs market size is expected to reach USD 8.17 billion by 2034, according to a new study by Polaris Market Research. The report "Erythropoietin Drugs Market Size, Share, Trends, Industry Analysis Report: By Type (Biologics and Biosimilars), Product, Application, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The erythropoietin drugs market comprises pharmaceutical agents that stimulate red blood cell production, primarily used to treat anemia associated with chronic kidney disease, cancer chemotherapy, and other medical conditions.

The market is experiencing steady growth due to the increasing prevalence of chronic diseases, rising demand for biosimilars, and advancements in drug formulations. Favorable regulatory policies supporting biosimilar approvals and expanding healthcare access in emerging markets present significant opportunities for market expansion.

Key erythropoietin drugs market trends include the development of long-acting formulations, strategic collaborations, and growing investment in research and development. Overall, the market is driven by the need for effective anemia management, cost-effective treatment options, and the continuous evolution of erythropoietin therapies.

Erythropoietin Drugs Market Report Highlights

Based on application, the renal diseases segment dominated the market in 2024, owing to the widespread incidence of chronic kidney disease (CKD). This condition frequently causes anemia due to impaired erythropoietin production in damaged kidneys, creating substantial demand for EPO therapies.
By type, biosimilars are witnessing significant growth due to patent expirations of biologic erythropoietin drugs and increasing demand for cost-effective treatment options. Regulatory support and expanding biosimilar adoption in emerging markets further drive this segment.
In 2024, North America holds the largest share in the erythropoietin drugs market, primarily due to the high prevalence of chronic kidney disease (CKD) and cancer, which often lead to anemia requiring erythropoietin therapy.
The Asia Pacific erythropoietin drugs market is witnessing significant growth, primarily due to the high prevalence of anemia and chronic kidney disease, especially in countries like India and China.
Notable companies include Amgen Inc.; Johnson & Johnson; F. Hoffmann-La Roche Ltd.; Pfizer Inc.; Novartis AG; Biocon Limited; Teva Pharmaceutical Industries Ltd.; Dr. Reddy's Laboratories Ltd.; LG Chem Ltd.; Wockhardt Ltd.; Intas Pharmaceuticals Ltd.; Sun Pharmaceutical Industries Ltd.; Celltrion Inc.; Kyowa Kirin Co., Ltd.; and Swedish Orphan Biovitrum AB.

Polaris Market Research has segmented the erythropoietin drugs market report on the basis of type, product, application, and region:

By Type Outlook (Revenue - USD Billion, 2020-2034)

Biologics
Biosimilars

By Product Outlook (Revenue - USD Billion, 2020-2034)

Erythropoietin
Darbepoetin-alfa

By Application Outlook (Revenue - USD Billion, 2020-2034)

Cancer
Renal Diseases
Neurology
Others

By Regional Outlook (Revenue - USD Billion, 2020-2034)

North America
US
Canada
Europe
Germany
France
UK
Italy
Spain
Netherlands
Russia
Rest of Europe
Asia Pacific
China
Japan
India
Malaysia
South Korea
Indonesia
Australia
Vietnam
Rest of Asia Pacific
Middle East & Africa
Saudi Arabia
UAE
Israel
South Africa
Rest of Middle East & Africa
Latin America
Mexico
Brazil
Argentina
Rest of Latin America

Product Code: PM3354

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Source
- 3.2.1. Primary Source
- 3.2.2. Secondary Source

4. Global Erythropoietin Drugs Market Insights

4.1. Erythropoietin Drugs Market - Market Snapshot
4.2. Erythropoietin Drugs Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. Rising Prevalence of Chronic Kidney Disease
  - 4.2.1.2. Increasing Incidence of Cancer
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. Stringent Regulatory Framework
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Erythropoietin Drugs Market Application Trends
4.6. Value Chain Analysis
4.7. COVID-19 Impact Analysis

5. Global Erythropoietin Drugs Market, by Type

5.1. Key Findings
5.2. Introduction
- 5.2.1. Global Erythropoietin Drugs Market, by Type, 2020-2034 (USD Billion)
5.3. Biologics
- 5.3.1. Global Erythropoietin Drugs Market, by Biologics, by Region, 2020-2034 (USD Billion)
5.4. Biosimilars
- 5.4.1. Global Erythropoietin Drugs Market, by Biosimilars, by Region, 2020-2034 (USD Billion)

6. Global Erythropoietin Drugs Market, by Product

6.1. Key Findings
6.2. Introduction
- 6.2.1. Global Erythropoietin Drugs Market, by Product, 2020-2034 (USD Billion)
6.3. Erythropoietin
- 6.3.1. Global Erythropoietin Drugs Market, by Erythropoietin, by Region, 2020-2034 (USD Billion)
6.4. Darbepoetin-alfa
- 6.4.1. Global Erythropoietin Drugs Market, by Darbepoetin-alfa, by Region, 2020-2034 (USD Billion)

7. Global Erythropoietin Drugs Market, by Application

7.1. Key Findings
7.2. Introduction
- 7.2.1. Global Erythropoietin Drugs Market, by Application, 2020-2034 (USD Billion)
7.3. Cancer
- 7.3.1. Global Erythropoietin Drugs Market, by Cancer, by Region, 2020-2034 (USD Billion)
7.4. Renal Diseases
- 7.4.1. Global Erythropoietin Drugs Market, by Renal Diseases, by Region, 2020-2034 (USD Billion)
7.5. Neurology
- 7.5.1. Global Erythropoietin Drugs Market, by Neurology, by Region, 2020-2034 (USD Billion)
7.6. Others
- 7.6.1. Global Erythropoietin Drugs Market, by Others, by Region, 2020-2034 (USD Billion)

8. Global Erythropoietin Drugs Market, by Geography

8.1. Key Findings
8.2. Introduction
- 8.2.1. Erythropoietin Drugs Market Assessment, By Geography, 2020-2034 (USD Billion)
8.3. Erythropoietin Drugs Market - North America
- 8.3.1. North America: Erythropoietin Drugs Market, by Type, 2020-2034 (USD Billion)
- 8.3.2. North America: Erythropoietin Drugs Market, by Product, 2020-2034 (USD Billion)
- 8.3.3. North America: Erythropoietin Drugs Market, by Application, 2020-2034 (USD Billion)
- 8.3.4. Erythropoietin Drugs Market - U.S.
  - 8.3.4.1. U.S.: Erythropoietin Drugs Market, by Type, 2020-2034 (USD Billion)
  - 8.3.4.2. U.S.: Erythropoietin Drugs Market, by Product, 2020-2034 (USD Billion)
  - 8.3.4.3. U.S.: Erythropoietin Drugs Market, by Application, 2020-2034 (USD Billion)
- 8.3.5. Erythropoietin Drugs Market - Canada
  - 8.3.5.1. Canada: Erythropoietin Drugs Market, by Type, 2020-2034 (USD Billion)
  - 8.3.5.2. Canada: Erythropoietin Drugs Market, by Product, 2020-2034 (USD Billion)
  - 8.3.5.3. Canada: Erythropoietin Drugs Market, by Application, 2020-2034 (USD Billion)
8.4. Erythropoietin Drugs Market - Europe
- 8.4.1. Europe: Erythropoietin Drugs Market, by Type, 2020-2034 (USD Billion)
- 8.4.2. Europe: Erythropoietin Drugs Market, by Product, 2020-2034 (USD Billion)
- 8.4.3. Europe: Erythropoietin Drugs Market, by Application, 2020-2034 (USD Billion)
- 8.4.4. Erythropoietin Drugs Market - UK
  - 8.4.4.1. UK: Erythropoietin Drugs Market, by Type, 2020-2034 (USD Billion)
  - 8.4.4.2. UK: Erythropoietin Drugs Market, by Product, 2020-2034 (USD Billion)
  - 8.4.4.3. UK: Erythropoietin Drugs Market, by Application, 2020-2034 (USD Billion)
- 8.4.5. Erythropoietin Drugs Market - France
  - 8.4.5.1. France: Erythropoietin Drugs Market, by Type, 2020-2034 (USD Billion)
  - 8.4.5.2. France: Erythropoietin Drugs Market, by Product, 2020-2034 (USD Billion)
  - 8.4.5.3. France: Erythropoietin Drugs Market, by Application, 2020-2034 (USD Billion)
- 8.4.6. Erythropoietin Drugs Market - Germany
  - 8.4.6.1. Germany: Erythropoietin Drugs Market, by Type, 2020-2034 (USD Billion)
  - 8.4.6.2. Germany: Erythropoietin Drugs Market, by Product, 2020-2034 (USD Billion)
  - 8.4.6.3. Germany: Erythropoietin Drugs Market, by Application, 2020-2034 (USD Billion)
- 8.4.7. Erythropoietin Drugs Market - Italy
  - 8.4.7.1. Italy: Erythropoietin Drugs Market, by Type, 2020-2034 (USD Billion)
  - 8.4.7.2. Italy: Erythropoietin Drugs Market, by Product, 2020-2034 (USD Billion)
  - 8.4.7.3. Italy: Erythropoietin Drugs Market, by Application, 2020-2034 (USD Billion)
- 8.4.8. Erythropoietin Drugs Market - Spain
  - 8.4.8.1. Spain: Erythropoietin Drugs Market, by Type, 2020-2034 (USD Billion)
  - 8.4.8.2. Spain: Erythropoietin Drugs Market, by Product, 2020-2034 (USD Billion)
  - 8.4.8.3. Spain: Erythropoietin Drugs Market, by Application, 2020-2034 (USD Billion)
- 8.4.9. Erythropoietin Drugs Market - Netherlands
  - 8.4.9.1. Netherlands: Erythropoietin Drugs Market, by Type, 2020-2034 (USD Billion)
  - 8.4.9.2. Netherlands: Erythropoietin Drugs Market, by Product, 2020-2034 (USD Billion)
  - 8.4.9.3. Netherlands: Erythropoietin Drugs Market, by Application, 2020-2034 (USD Billion)
- 8.4.10. Erythropoietin Drugs Market - Russia
  - 8.4.10.1. Russia: Erythropoietin Drugs Market, by Type, 2020-2034 (USD Billion)
  - 8.4.10.2. Russia: Erythropoietin Drugs Market, by Product, 2020-2034 (USD Billion)
  - 8.4.10.3. Russia: Erythropoietin Drugs Market, by Application, 2020-2034 (USD Billion)
- 8.4.11. Erythropoietin Drugs Market - Rest of Europe
  - 8.4.11.1. Rest of Europe: Erythropoietin Drugs Market, by Type, 2020-2034 (USD Billion)
  - 8.4.11.2. Rest of Europe: Erythropoietin Drugs Market, by Product, 2020-2034 (USD Billion)
  - 8.4.11.3. Rest of Europe: Erythropoietin Drugs Market, by Application, 2020-2034 (USD Billion)
8.5. Erythropoietin Drugs Market - Asia Pacific
- 8.5.1. Asia Pacific: Erythropoietin Drugs Market, by Type, 2020-2034 (USD Billion)
- 8.5.2. Asia Pacific: Erythropoietin Drugs Market, by Product, 2020-2034 (USD Billion)
- 8.5.3. Asia Pacific: Erythropoietin Drugs Market, by Application, 2020-2034 (USD Billion)
- 8.5.4. Erythropoietin Drugs Market - China
  - 8.5.4.1. China: Erythropoietin Drugs Market, by Type, 2020-2034 (USD Billion)
  - 8.5.4.2. China: Erythropoietin Drugs Market, by Product, 2020-2034 (USD Billion)
  - 8.5.4.3. China: Erythropoietin Drugs Market, by Application, 2020-2034 (USD Billion)
- 8.5.5. Erythropoietin Drugs Market - India
  - 8.5.5.1. India: Erythropoietin Drugs Market, by Type, 2020-2034 (USD Billion)
  - 8.5.5.2. India: Erythropoietin Drugs Market, by Product, 2020-2034 (USD Billion)
  - 8.5.5.3. India: Erythropoietin Drugs Market, by Application, 2020-2034 (USD Billion)
- 8.5.6. Erythropoietin Drugs Market - Malaysia
  - 8.5.6.1. Malaysia: Erythropoietin Drugs Market, by Type, 2020-2034 (USD Billion)
  - 8.5.6.2. Malaysia: Erythropoietin Drugs Market, by Product, 2020-2034 (USD Billion)
  - 8.5.6.3. Malaysia: Erythropoietin Drugs Market, by Application, 2020-2034 (USD Billion)
- 8.5.7. Erythropoietin Drugs Market - Japan
  - 8.5.7.1. Japan: Erythropoietin Drugs Market, by Type, 2020-2034 (USD Billion)
  - 8.5.7.2. Japan: Erythropoietin Drugs Market, by Product, 2020-2034 (USD Billion)
  - 8.5.7.3. Japan: Erythropoietin Drugs Market, by Application, 2020-2034 (USD Billion)
- 8.5.8. Erythropoietin Drugs Market - Indonesia
  - 8.5.8.1. Indonesia: Erythropoietin Drugs Market, by Type, 2020-2034 (USD Billion)
  - 8.5.8.2. Indonesia: Erythropoietin Drugs Market, by Product, 2020-2034 (USD Billion)
  - 8.5.8.3. Indonesia: Erythropoietin Drugs Market, by Application, 2020-2034 (USD Billion)
- 8.5.9. Erythropoietin Drugs Market - South Korea
  - 8.5.9.1. South Korea: Erythropoietin Drugs Market, by Type, 2020-2034 (USD Billion)
  - 8.5.9.2. South Korea: Erythropoietin Drugs Market, by Product, 2020-2034 (USD Billion)
  - 8.5.9.3. South Korea: Erythropoietin Drugs Market, by Application, 2020-2034 (USD Billion)
- 8.5.10. Erythropoietin Drugs Market - Australia
  - 8.5.10.1. Australia: Erythropoietin Drugs Market, by Type, 2020-2034 (USD Billion)
  - 8.5.10.2. Australia: Erythropoietin Drugs Market, by Product, 2020-2034 (USD Billion)
  - 8.5.10.3. Australia: Erythropoietin Drugs Market, by Application, 2020-2034 (USD Billion)
- 8.5.11. Erythropoietin Drugs Market - Rest of Asia Pacific
  - 8.5.11.1. Rest of Asia Pacific: Erythropoietin Drugs Market, by Type, 2020-2034 (USD Billion)
  - 8.5.11.2. Rest of Asia Pacific: Erythropoietin Drugs Market, by Product, 2020-2034 (USD Billion)
  - 8.5.11.3. Rest of Asia Pacific: Erythropoietin Drugs Market, by Application, 2020-2034 (USD Billion)
8.6. Erythropoietin Drugs Market - Middle East & Africa
- 8.6.1. Middle East & Africa: Erythropoietin Drugs Market, by Type, 2020-2034 (USD Billion)
- 8.6.2. Middle East & Africa: Erythropoietin Drugs Market, by Product, 2020-2034 (USD Billion)
- 8.6.3. Middle East & Africa: Erythropoietin Drugs Market, by Application, 2020-2034 (USD Billion)
- 8.6.4. Erythropoietin Drugs Market - Saudi Arabia
  - 8.6.4.1. Saudi Arabia: Erythropoietin Drugs Market, by Type, 2020-2034 (USD Billion)
  - 8.6.4.2. Saudi Arabia: Erythropoietin Drugs Market, by Product, 2020-2034 (USD Billion)
  - 8.6.4.3. Saudi Arabia: Erythropoietin Drugs Market, by Application, 2020-2034 (USD Billion)
- 8.6.5. Erythropoietin Drugs Market - UAE
  - 8.6.5.1. UAE: Erythropoietin Drugs Market, by Type, 2020-2034 (USD Billion)
  - 8.6.5.2. UAE: Erythropoietin Drugs Market, by Product, 2020-2034 (USD Billion)
  - 8.6.5.3. UAE: Erythropoietin Drugs Market, by Application, 2020-2034 (USD Billion)
- 8.6.6. Erythropoietin Drugs Market - Israel
  - 8.6.6.1. Israel: Erythropoietin Drugs Market, by Type, 2020-2034 (USD Billion)
  - 8.6.6.2. Israel: Erythropoietin Drugs Market, by Product, 2020-2034 (USD Billion)
  - 8.6.6.3. Israel: Erythropoietin Drugs Market, by Application, 2020-2034 (USD Billion)
- 8.6.7. Erythropoietin Drugs Market - South Africa
  - 8.6.7.1. South Africa: Erythropoietin Drugs Market, by Type, 2020-2034 (USD Billion)
  - 8.6.7.2. South Africa: Erythropoietin Drugs Market, by Product, 2020-2034 (USD Billion)
  - 8.6.7.3. South Africa: Erythropoietin Drugs Market, by Application, 2020-2034 (USD Billion)
- 8.6.8. Erythropoietin Drugs Market - Rest of Middle East & Africa
  - 8.6.8.1. Rest of Middle East & Africa: Erythropoietin Drugs Market, by Type, 2020-2034 (USD Billion)
  - 8.6.8.2. Rest of Middle East & Africa: Erythropoietin Drugs Market, by Product, 2020-2034 (USD Billion)
  - 8.6.8.3. Rest of Middle East & Africa: Erythropoietin Drugs Market, by Application, 2020-2034 (USD Billion)
8.7. Erythropoietin Drugs Market - Latin America
- 8.7.1. Latin America: Erythropoietin Drugs Market, by Type, 2020-2034 (USD Billion)
- 8.7.2. Latin America: Erythropoietin Drugs Market, by Product, 2020-2034 (USD Billion)
- 8.7.3. Latin America: Erythropoietin Drugs Market, by Application, 2020-2034 (USD Billion)
- 8.7.4. Erythropoietin Drugs Market - Mexico
  - 8.7.4.1. Mexico: Erythropoietin Drugs Market, by Type, 2020-2034 (USD Billion)
  - 8.7.4.2. Mexico: Erythropoietin Drugs Market, by Product, 2020-2034 (USD Billion)
  - 8.7.4.3. Mexico: Erythropoietin Drugs Market, by Application, 2020-2034 (USD Billion)
- 8.7.5. Erythropoietin Drugs Market - Brazil
  - 8.7.5.1. Brazil: Erythropoietin Drugs Market, by Type, 2020-2034 (USD Billion)
  - 8.7.5.2. Brazil: Erythropoietin Drugs Market, by Product, 2020-2034 (USD Billion)
  - 8.7.5.3. Brazil: Erythropoietin Drugs Market, by Application, 2020-2034 (USD Billion)
- 8.7.6. Erythropoietin Drugs Market - Argentina
  - 8.7.6.1. Argentina: Erythropoietin Drugs Market, by Type, 2020-2034 (USD Billion)
  - 8.7.6.2. Argentina: Erythropoietin Drugs Market, by Product, 2020-2034 (USD Billion)
  - 8.7.6.3. Argentina: Erythropoietin Drugs Market, by Application, 2020-2034 (USD Billion)
- 8.7.7. Erythropoietin Drugs Market - Rest of Latin America
  - 8.7.7.1. Rest of Latin America: Erythropoietin Drugs Market, by Type, 2020-2034 (USD Billion)
  - 8.7.7.2. Rest of Latin America: Erythropoietin Drugs Market, by Product, 2020-2034 (USD Billion)
  - 8.7.7.3. Rest of Latin America: Erythropoietin Drugs Market, by Application, 2020-2034 (USD Billion)

9. Competitive Landscape

9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

10.1. Amgen Inc.
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Product Benchmarking
- 10.1.4. Recent Development
10.2. Biocon Limited
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Product Benchmarking
- 10.2.4. Recent Development
10.3. Celltrion Inc.
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Product Benchmarking
- 10.3.4. Recent Development
10.4. Dr. Reddy's Laboratories Ltd.
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Product Benchmarking
- 10.4.4. Recent Development
10.5. F. Hoffmann-La Roche Ltd.
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Product Benchmarking
- 10.5.4. Recent Development
10.6. Intas Pharmaceuticals Ltd.
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Product Benchmarking
- 10.6.4. Recent Development
10.7. Johnson & Johnson
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Product Benchmarking
- 10.7.4. Recent Development
10.8. Kyowa Kirin Co., Ltd.
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Product Benchmarking
- 10.8.4. Recent Development
10.9. LG Chem Ltd.
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Product Benchmarking
- 10.9.4. Recent Development
10.10. Novartis AG
- 10.10.1. Company Overview
- 10.10.2. Financial Performance
- 10.10.3. Product Benchmarking
- 10.10.4. Recent Development